Biovista Inc., Charlottesville, July 7, 2010:  Biovista today announced that it will be presenting at the 8th International Conference on Pathways, Networks, and Systems Medicine to be held at the Sheraton rhodes hotel in Rhodes, July 9 – 14, 2010.

Dr Andreas Persidis, CEO of Biovista Inc. will present on Sunday 11 July, 11:45am local time (4:45am EST). Dr. Persidis’ presentation entitled “Drug repurposing and adverse event prediction using high-throughput literature analysis: case studies” will cover the company’s repositioning and adverse event prediction platform, findings on the platform’s predictive accuracy as well as successful case studies from its use in the field.

About Biovista’s repositioning pipeline and technology platform

Biovista applies high-throughput discovery efforts to finding solutions for commercially relevant unmet medical needs.  Biovista’s proprietary repositioning technology allows the company’s experts to perform mechanism-of-action based analyses and systematically assess clinical outcomes in any therapeutic area of interest, at relatively low cost and very short time spans. The company is presently using this platform to develop its own pipeline of repositioned drugs in areas such as CNS, cardiovascular disease, oncology and auto-immune diseases.


For more information, please contact:

Dr. Andreas Persidis

Biovista, Inc.

+30 697 338 1717